Requiring clinical testing for drugs to support a dietary supplement claim would cause a “wholesale change” in the substantiation standard for supplements, industry trade groups argue in support of dismissing a Federal Trade Commission complaint against [Quincy Bioscience LLC].
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?